programmed death ligand 1 - Globe Thesis

Keyword [programmed death ligand 1] Result: 121 - 140 \| Page: 7 of 8
121.	Negative Correlation Of MicroRNA And PD-L1 Expression In Breast Cancer Cells And Target Blocking The Expression Of PD-L1
122.	Clinical Role Of CD39 Expression In Head And Neck Squamous Cell Carcinoma And Its Related Impact Factors
123.	Theoretical Investigations On The Mechanism Of Dimerizationmodes Transformation In Programmed Death Ligand-1 Protein
124.	Identification And Characterization Of Small Molecule Inhibitors Against PD-L1
125.	The Roles And Related Mechanisms Of Low-density Granulocytes On T-SPOT.TB Detection
126.	The Expression And Significance Of PD-L1 In Different Stages Of Helicobacter Pylori Gastritis
127.	Expressive Levels And Clinical Significance Of SPD-1 And SPD-L1 In Peripheral Blood Of Patients With Hematological Malignancies
128.	SYVN1 Ubiquitinates FoxO1 To Induce P-catenin Nuclear Translocation,PD-LI-mediated Metastasis,and Immune Evasion Of Hepatocellular Carcinoma
129.	Endothelial Targeting Blockade Of Programmed Death-Ligand1 (PD-L1) Attenuates Sepsis Induced Acute Lung Injury
130.	The Application Study On PD-L1 Expression,Immunotherapy Efficacy And Complication Prediction In Non-small Cell Lung Cancer Based On CT Radiomics
131.	Experimental Study Of Sorafenib Combined With Anti-PD-L1 Antibody In The Treatment Of Hepatocellular Carcinoma And Multimodal Imaging Evaluation Of Its Efficacy
132.	IL-2 Mutein Enhance The Efficacy Of PD-1 Monoclonal Antibody Immunotherapy And Its Related Mechanisms
133.	Effects Of Secretion Phenotype Of Senescent Tumor Cells On Tumor Migration, Invasion And Tumor Immune Micro-Environment And Its Mechanism
134.	Long Intergenic Non-Coding RNA LINC01088 Facilitates Malignant Phenotypes And Immune Escape Of Colorectal Cancer
135.	Detection Of DNA Damage And Analysis Of PD-L1 Expression In Ovarian Cancer By Modified DNA Damage Detection Technique
136.	Clinical Study On The Relationship Between The Expression Of Programmed Death Ligand-1 And Tumor Grade And Clinical Stage Of Upper Urothelial Carcinoma
137.	Features Of Patients With Advanced EGFR-mutated Non-small Cell Lung Cancer Benefiting From Immune Checkpoint Inhibitors
138.	Expression Of PD-1/PD-L1 In Different Histological Subtypes Of Nasopharyngeal Carcinoma And Its Clinical Significance
139.	The Interference And Related Mechanisms Of Low Density Granulocytes On T-SPOT.TB Results In Rheumatoid Arthritis
140.	PTPRD Affects The Expression Of PD-L1 In Human Hepatocellular Carcinoma By Down-regulating STAT3
<<First <Prev Next> Last>> Jump to